Affymetrix's latest offering to researchers studying microRNA continues to stand alone in the marketplace.

A month after the firm launched catalog and custom genotyping arrays for the genome-wide evaluation of microRNA target sites, representatives for Agilent Technologies and Exiqon, two firms that compete against Affy in the miRNA array market, said they have no intention of launching a similar product. And while an Illumina representative said the firm plans to introduce arrays that include some similar content, a direct competitive offering is not planned.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.